Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “18 Years and Older”

254 trials

Showing 20 of 254 results

Not applicableStudy completedNCT04923464
What this trial is testing

A Decentralized Study to Evaluate Physical Activity and Cough Frequency Using Wearable Technology in Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 51
Large-scale testing (Phase 3)Study completedNCT04904471
What this trial is testing

A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells)

Who this might be right for
COVID-19
WestVac Biopharma Co., Ltd. 39,663
Early research (Phase 1)UnknownNCT04636333
What this trial is testing

Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell)

Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention 216
Testing effectiveness (Phase 2)Active Not RecruitingNCT07204964
What this trial is testing

Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above

Who this might be right for
Influenza, Human
GlaxoSmithKline 971
Large-scale testing (Phase 3)Study completedNCT01440387
What this trial is testing

Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older

Who this might be right for
Influenza
GlaxoSmithKline 112
Large-scale testing (Phase 3)Study completedNCT00319098
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above

Who this might be right for
Influenza
GlaxoSmithKline 5,075
Large-scale testing (Phase 3)Study completedNCT00294047
What this trial is testing

Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 5,752
Testing effectiveness (Phase 2)Looking for participantsNCT07431853
What this trial is testing

Learn About mRNA Vaccines Against Influenza in Adults

Who this might be right for
Healthy Adults
Pfizer 770
Post-approval studies (Phase 4)Study completedNCT00832585
What this trial is testing

Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Rush University Medical Center 5
Testing effectiveness (Phase 2)Study completedNCT05323435
What this trial is testing

Immunogenicity and Safety Study of Recombinant Two-Component COVID-19 Vaccine (CHO Cell)(ReCOV)

Who this might be right for
COVID-19
Jiangsu Rec-Biotechnology Co., Ltd. 300
Testing effectiveness (Phase 2)Study completedNCT05373472
What this trial is testing

Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

Who this might be right for
COVID-19
CanSino Biologics Inc. 150
Large-scale testing (Phase 3)Study completedNCT00380211
What this trial is testing

Safety and Immunogenicity of FluLaval™ TR and Fluarix® (Influenza Vaccines) in Young and Older Adults

Who this might be right for
Influenza
GlaxoSmithKline 660
Not applicableUnknownNCT05886790
What this trial is testing

A Clinical Trial on Booster Immunization of Two COVID-19 Vaccines Constructed From Different Technical Routes

Who this might be right for
COVID-19
Zhongnan Hospital 450
Large-scale testing (Phase 3)Study completedNCT00197288
What this trial is testing

Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines

Who this might be right for
Influenza
GlaxoSmithKline 1,847
Early research (Phase 1)UnknownNCT05939596
What this trial is testing

A Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)

Who this might be right for
SARS-CoV-2
AIM Vaccine Co., Ltd. 60
Large-scale testing (Phase 3)Study completedNCT00979602
What this trial is testing

Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older

Who this might be right for
Influenza
GlaxoSmithKline 4,048
Large-scale testing (Phase 3)Ended earlyNCT05683600
What this trial is testing

Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older

Who this might be right for
COVID-19
Guangzhou Patronus Biotech Co., Ltd. 3,000
Large-scale testing (Phase 3)Active Not RecruitingNCT07284654
What this trial is testing

Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49

Who this might be right for
Pneumococcal Vaccines
Vaxcyte, Inc. 4,049
Large-scale testing (Phase 3)Study completedNCT00384475
What this trial is testing

Ciclesonide Nasal Spray in Patients 18 Years and Older With Seasonal Allergic Rhinitis (BY9010/M1-413)

Who this might be right for
Rhinitis, Allergic, SeasonalHay Fever
AstraZeneca 500
Large-scale testing (Phase 3)Study completedNCT00268723
What this trial is testing

Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB

Who this might be right for
Exercise-induced Bronchospasm
Sumitomo Pharma America, Inc. 15
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation